Are sick kids getting the right antibiotic dose? study aims to find out

NCT ID NCT02456974

Recruiting now Knowledge-focused Sponsor: University Hospital, Ghent Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether current antibiotic doses work well for children in intensive care. Researchers will take blood samples from 640 children receiving common antibiotics to measure drug levels. The goal is to see if these doses reach high enough concentrations to fight infections effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors give the right antibiotic doses to sick children in intensive care, improving treatment and reducing side effects.
What could go wrong: This is an observational study, not testing a new drug. It only measures drug levels, so it won't directly change treatment yet. Results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMIKACIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMIKACIN AMOXICILLIN-CLAVULANATE CIPROFLOXACIN MEROPENEM PHARMACOKINETICS PIPERACILLIN-TAZOBACTAM TEICOPLANIN VANCOMYCIN

Are sick kids getting the right antibiotic dose? study aims to find out

Summary

What this could mean

Get notified about this study

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions